Immune Response of a Two-Dose Heterologous Ebola Vaccine Regimen: Summary of Three African Clinical Trials Using a Single Validated Filovirus Animal Nonclinical Group Enzyme-Linked Immunosorbent Assay in a Single Accredited Laboratory.Chelsea McLean,Houreratou Barry,Mark Kieh,Zacchaeus Anywaine,Baimba Tapima Rogers,Seydou Doumbia,Sodiomon B. Sirima,Alimamy Serry-Bangura,Abdoul Habib Beavogui,Auguste Gaddah,Michael Katwere,Jenny Hendriks,Babajide Keshinro,Serge Eholie,Hannah Kibuuka,Stephen B. Kennedy,Omu Anzala,Mohamed Samai,Eric D'Ortenzio,Bailah Leigh,Samba Sow,Rodolphe Thiebaut,Brian Greenwood,Deborah Watson-Jones,Macaya Douoguih,Kerstin Luhn,Cynthia RobinsonEBioMedicine（2023）引用 0|浏览48暂无评分关键词Ad26,ZEBOV,MVA-BN-Filo,Africa,Ebola,VaccineAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
